Lymphoma is diagnosed through a combination of physical examination, blood tests, a biopsy of an enlarged lymph node, and imaging scans. The biopsy is the most critical step, as it’s the only way to confirm whether lymphoma is present and identify its specific type. The full diagnostic process, from initial suspicion to a confirmed diagnosis with staging, typically unfolds over several weeks.
What Raises Suspicion in a Physical Exam
The diagnostic process usually starts when you or your doctor notice a swollen lymph node. Not every swollen node signals lymphoma. Doctors evaluate specific characteristics to determine whether further testing is warranted. A node in the neck or armpit generally needs to be larger than 2 centimeters to be considered significant, while nodes above the collarbone raise concern at just 1 centimeter. Lymph nodes that feel rubbery are classically associated with lymphoma, as opposed to the hard, fixed nodes more typical of other cancers or the tender, squishy nodes seen with infections.
Symmetry matters too. If both sides of your neck are equally swollen, that’s more likely an infection or immune response. Asymmetric swelling, where one side is noticeably larger, is more suspicious for lymphoma. Your doctor will also ask about what are known as “B symptoms”: unexplained fevers above 38°C (100.4°F), drenching night sweats that soak through your clothes, and losing more than 10% of your body weight over six months without trying. These symptoms don’t confirm lymphoma on their own, but they help doctors gauge urgency and, later, determine staging.
Blood Tests: What They Show and Don’t Show
No blood test can diagnose lymphoma by itself, but several tests help build the picture. A complete blood count (CBC) with differential breaks down the types and numbers of white blood cells, which can reveal abnormal patterns. An erythrocyte sedimentation rate (ESR) measures inflammation in the body, and elevated levels can point toward lymphoma. Lactate dehydrogenase (LDH) reflects how quickly cells are growing and dying. A high LDH level suggests a large amount of cell turnover, which can indicate aggressive disease.
These results help your medical team decide how quickly to move toward a biopsy and what type of lymphoma might be involved, but they’re supporting evidence rather than proof.
The Biopsy: How Lymphoma Is Confirmed
A biopsy is the only way to definitively diagnose lymphoma. In most cases, doctors prefer an excisional biopsy, where a surgeon removes an entire lymph node through a small incision. This provides the pathologist with the most tissue to examine, which is important because lymphoma diagnosis depends on seeing the overall architecture of the node, not just individual cells.
When the suspicious node is deep in the chest or abdomen, or when there are medical reasons to avoid surgery, a core needle biopsy may be used instead. This involves inserting a thick needle to extract a cylinder of tissue. It’s less invasive but collects a smaller sample. Sometimes the material isn’t adequate for a complete diagnosis, and a follow-up excisional biopsy becomes necessary.
Fine needle aspiration, which uses a very thin needle, is generally not recommended for an initial lymphoma diagnosis. It can identify abnormal cells but doesn’t preserve enough tissue structure to determine the specific subtype, which is essential for choosing the right treatment. Results from a lymph node biopsy typically come back within two weeks.
How Pathologists Identify the Type
Once the tissue is removed, it goes through a detailed analysis that goes well beyond looking at cells under a microscope. Pathologists use a technique called immunohistochemistry, which involves staining the tissue with antibodies that bind to specific proteins on the surface of the cancer cells. The pattern of proteins present tells the pathologist exactly what type of lymphoma they’re dealing with.
For example, classic Hodgkin lymphoma cells strongly display a protein called CD30 but are negative for CD20. Nodular lymphocyte-predominant Hodgkin lymphoma, a rarer form, shows the opposite pattern: positive for CD20, negative for CD30. Most non-Hodgkin lymphomas are CD20-positive, which is clinically important because it determines whether certain targeted therapies will work.
The World Health Organization maintains the standard classification system for lymphomas, with the most recent edition published in July 2024. There are over 60 recognized subtypes, and the distinction between them matters enormously for treatment planning. This is why pathologists need enough tissue to work with and why an excisional biopsy is preferred.
PET-CT and Other Imaging Scans
After a biopsy confirms lymphoma, imaging scans map where the disease has spread. PET-CT scanning is the standard for Hodgkin lymphoma and most common non-Hodgkin lymphoma subtypes. This scan combines two types of imaging: a CT scan that shows the size and shape of lymph nodes and organs, and a PET scan that highlights areas of high metabolic activity (where cells are rapidly consuming sugar, as cancer cells tend to do).
Doctors interpret PET-CT results using a standardized five-point scoring system called the Deauville scale. A score of 1 means no abnormal activity at all, while a score of 5 indicates markedly increased activity well above what the liver shows. Scores of 1 through 3 are generally considered a complete metabolic response when assessed after treatment, while scores of 4 or 5 suggest active disease remains. This same scoring system is used both at diagnosis and later to measure how well treatment is working.
For certain slower-growing lymphoma subtypes that don’t light up well on PET scans, a contrast-enhanced CT scan alone may be used instead.
Staging: How Far It Has Spread
Staging determines how extensive the lymphoma is and directly influences treatment decisions. The system used is based on the Ann Arbor classification, with four stages:
- Stage I: Lymphoma is in a single lymph node region or a single organ outside the lymphatic system.
- Stage II: Two or more lymph node regions are involved, but all are on the same side of the diaphragm (the muscle separating your chest from your abdomen).
- Stage III: Lymph node regions on both sides of the diaphragm are involved.
- Stage IV: The disease has spread beyond the lymph nodes into organs like the liver, bone marrow, lungs, or cerebrospinal fluid.
Each stage also gets a letter designation. “A” means you have no systemic symptoms. “B” means you have one or more of the classic symptoms: fever, drenching night sweats, or significant weight loss. So a diagnosis of “Stage IIB” would mean lymphoma in multiple node regions on one side of the diaphragm, with B symptoms present.
Bone Marrow Biopsy
Some lymphoma subtypes require a bone marrow biopsy as part of staging. This involves inserting a needle into the back of the hip bone to extract a small core of marrow tissue. It’s done under local anesthesia and takes about 15 to 30 minutes. The procedure helps determine whether lymphoma cells have infiltrated the marrow, which would indicate Stage IV disease.
Whether you need one depends on the specific type of lymphoma. For follicular lymphoma, a bone marrow biopsy is standard during initial staging and is considered mandatory when disease appears localized. For marginal zone lymphoma, it’s recommended across most subtypes. In some cases, PET-CT imaging may be sufficient to evaluate the marrow without a separate biopsy, but this varies by subtype and clinical guidelines.
Lumbar Puncture for CNS Involvement
A lumbar puncture, or spinal tap, is not part of routine lymphoma diagnosis. It’s reserved for situations where there’s concern that lymphoma has reached the central nervous system. This includes patients with certain aggressive subtypes, those with neurological symptoms like progressive confusion or focal weakness, or those with brain imaging showing enhancing abnormalities.
The procedure involves collecting a small amount of cerebrospinal fluid from the lower back. A pathologist then examines it for lymphoma cells. If brain imaging shows a mass with significant swelling, a lumbar puncture is avoided because it could be dangerous, and a direct brain biopsy is performed instead.
The Full Timeline
From the first suspicious finding to a complete diagnosis with subtype and stage, the process typically takes three to six weeks. The initial visit and blood work happen within days. Scheduling and performing a biopsy may take one to two weeks, with pathology results returning within another two weeks. Staging scans and any additional biopsies, such as bone marrow, usually follow shortly after the pathology confirms lymphoma. The timeline can be compressed if symptoms are severe or the lymphoma appears aggressive, with some centers fast-tracking the entire workup within two weeks.